OPT - MCAP CO - Opthea Limited

The retrospective value of Opthea Limited (OPT) shares on the GURU.Markets platform, where the indicator stands at , is based on a cycle independent of the global economy, which renders the sector defensive. However, the business faces threats related to the high cost of research and the uncertainty surrounding the final tests of OPT-302. Furthermore, the efficacy of the therapy depends directly on strict adherence to temperature controls during the transportation of innovative agents.

Market capitalization represents the aggregate value of all shares, reflecting the current market valuation of the business. For Opthea Limited (OPT), this metric depends directly on the success of clinical trials for macular degeneration therapy in partnership with ophthalmology centers. By analyzing the company's market valuation history, an investor can see the trend of confidence in the drugs' potential. An upward trend confirms the capitalization of intellectual assets. Steady growth of this indicator suggests high fundamental reliability of the investments.